A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestion

British Journal of Urology

Volumn 79, Issue 5, 1997, Pages 781-784

  Png, J C D ^a,b   Tan, E ^a,b   Foo, K T ^a,b   Li, M K ^a,b   Cheng, C ^a,b   Rekhraj, I R ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Ciprofloxacin; Minimum inhibitory concentrations; Ofloxacin; Penetrance; Prophylaxis; Prostate surgery

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; OFLOXACIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHLAMYDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TISSUE LEVEL; GRAM NEGATIVE BACTERIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; PSEUDOMONAS; STAPHYLOCOCCUS; TRANSURETHRAL RESECTION;

EID: 0031395340     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00146.x     Document Type: Article

References (24)

1. Lee CT, Thirumoorthy T, Lim KB et al. Norfloxacin in the treatment of uncomplicated gonorrhoea in Singapore males. JAMA (SEA) 1986; 2 (suppl): 42-4
2. Madsen PO, Malek GH, Kahn JB. Single dose UTI prophylaxis in transurethral surgery. Drugs (Suppl Preprint) 1995; 49: 70-2
3. Riedasch G, Mohring K, Brkovic D. Concentration of ofloxacin in prostatic tissue during TURP. Drugs 1993; 45 (Suppl 3): 356
4. Paton JH, Reeves DS. Fluoroquinolone antibiotics, microbiology, pharmacokinetics and clinical use. Drugs 1988; 36: 193-228
5. Naber K, Bartosik-Wich B. Serum-und Urinkonzentrationen von Norfloxacin, Ciprofloxacinund Ofloxacin bei alteren urologischen Patienten. Forschritte der Antimikrobiellen und Antineoplastischen. Chemotherapie 1984; 3-5: 701-9
6. Monk JP, Campoli-Richards DM, Ofloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1987; 33: 346-91
7. Wise R, Donovan IA. Tissue penetration and metabolism of ciprofloxacin. Am J Med 1987; 82 (Suppl): 107
8. Boerema JBJ, Dalhoff A, Debruyne FM. Ciprofloxacin distribution in prostatic tissue and fluid following oral administration. Chemotherapy 1985; 31: 13-8
9. Nickel JC, Costerton JW. Coagulase-negative staphylococcus in chronic prostatitis. J Urol 1992; 147: 398-401
10. Pfau A. Re: Coagulase-negative staphylococcus in chronic prostatitis. Letter to the editor. J Urol 1993; 148: 1921-2
11. Meares EM, Stamey TA. Bacteriologic localisation patterns in bacterial prostatitis and urethritis. Invest Urol 1968; 5: 492-518
12. Meares EM. Acute and chronic prostatitis: diagnosis and treatment. Infect Dis Clin North Am 1987; 1: 855-73
13. Wedren H. On chronic prostatitis with special studies of Staphylococcus epidermidis. Scand J Urol Nephrol 1989; 123 suppl: 1-31
14. Doble A. Chronic prostatitis. Br J Urol 1994; 74: 537-41
15. Van Landuyt HW, Rummens JL, Boelaert J, Lambert AM. In vitro activity of ofloxacin compared with six other quinolones and five beta lactams. 24th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC 1984. Tokyo: Excerpta Medica 1985: 26-30
16. Mardh PA, Colleen S, Holmquist B. Chlamydia in chronic prostatitis. (Letter). Br Med J 1972; 4: 361
17. Bruce AW, Reid G. Prostatitis associated with Chlamydia trachomatis in six patients. J Urol 1989; 142: 1006-7
18. Shurbaji MS, Gupta PK. Myers J. Immunohistochemical demonstration of chlamydial antigens in association with prostatitis. Mod Pathol 1988; 1: 348-51
19. Berger RE, Krieger JN, Kessler D et al. Case control study of men with suspected chronic idiopathic prostatitis. J Urol 1989; 141: 328-31
20. Doble A, Thomas BJ, Walker MM et al. The role of Chlamydia trachomatis in chronic abacterial prostatitis: a study using ultrasound guided biopsy. J Urol 1989; 141: 332-3
21. Shortliffe LMD, Wehner N. The characterisation of bacterial prostatitis by prostatic immunoglobins. Medicine 1986; 65: 399-4
22. Shortliffe LMD, Sellers RG, Schacter J. The characterisation of nonbacterial prostatitis: search for an etiology. J Urol 1992; 148: 1461-6
23. Weider W, Brunner H, Krause W. Quantitive culture of Ureaplasma urealyticum in patients with chronic prostatitis or prostatosis. J Urol 1980; 124: 622-5
24. Ohkawa M, Yamaguchi K, Tokunaya S, Nakashima T, Fujita S. Ureaplasma urealyticum in the urogenital tract of patients with chronic prostatitis or related symptomatology. Br J Urol 1993; 72: 918-21